High Uptake for RSV Vaccine and Nirsevimab Among Pregnant Women, Infants
Amongst eligible pregnant women, 64.0% received the RSVpreF vaccine, and 70.1% of eligible neonates received nirsevimab, according to a new study that was published in JAMA Network Open, yesterday. The investigators write that this translates to more than 80% coverage against RSV during all but the first month of the study.1 “This study suggests that […]
Ginkgo Bioworks Targets Infectious Disease with Rapid Respiratory Virus Detection System
Ginkgo Bioworks is collaborating with the European Health and Digital Executive Agency (HaDEA) in a project valued at up to €24 million to develop rapid metagenomic sequencing for respiratory virus detection. The funding comes from the EU4Health program and aligns with the priorities of the Health Emergency Preparedness and Response Authority (HERA). The RANGER (RApid […]
Groundbreaking study shows potential of new mRNA vaccine to help fight tuberculosis
A new vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pioneering pre-clinical trials, as part of a successful collaboration between three leading Australian research institutions. A study into the vaccine’s effectiveness, published in eBioMedicine, was led by experts from the Sydney Infectious Diseases Institute at University of Sydney, the […]
Paxlovid Does Not Significantly Reduce COVID-19 Hospitalization, Mortality in Vaccinated Older Adults
In a large study published today, nirmatrelvir-ritonavir (Paxlovid) use was not found to reduce hospitalizations and mortality in adults 70 years of age and older who were vaccinated.1 “There were no significant differences just below vs just above age 70 years (per 100000 patients per month) in COVID-19–related hospitalizations (39.5 vs 42.9; absolute difference, 3.4; […]
Persistent Fever as a Key Mortality Predictor in MRSA Bacteremia
Sean Ong Image credits: LinkedIn A post hoc analysis of the CAMERA2 randomized clinical trial has identified persistent fever after 72 hours as a key predictor of increased mortality in patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteremia. In contrast, white blood cell (WBC) count and C-reactive protein (CRP) levels did not show the same predictive […]
Early Release – Antiviral Susceptibility of Clade 2.3.2.1c and 2.3.4.4b H5N1 Viruses from Humans, 2023–2024 – Volume 31, Number 4—April 2025 – Emerging Infectious Diseases journal
Antiviral Susceptibility of Clade 2.3.2.1c and 2.3.4.4b H5N1 Viruses from Humans, 2023–2024 Volume 31, Number 4—April 2025 Altmetrics Click a source for Altmetric details What is the Altmetric Attention Score? The Altmetric Attention Score for a research output provides an indicator of the amount of attention that it has received. The score is derived from […]
Chikungunya in Réunion – Level 2 – Level 2 – Practice Enhanced Precautions – Travel Health Notices | Travelers’ Health
Chikungunya disease is caused by the chikungunya virus and is spread to humans through mosquito bites. Outbreaks have occurred in countries in Africa, Americas, Asia, Europe, the Caribbean, and Indian and Pacific Oceans. Most people infected with chikungunya virus develop some symptoms. Symptoms of chikungunya usually begin 3–7 days after a bite by an infected […]
